Thessaloniki, 2^nd of August 2013

Under the provisions of article 10 par. 1 of L. 3340/2005 and article 2 of Board's Decision 3/347/12-07-2005 of Hellenic Capital Market Commission, ELGEKA S.A. informs the investing public and its shareholders of the following:

The unsolicited Extraordinary General Meeting of its subsidiary company "MEDIHELM S.A." decided on 31/07/2013 to increase its share capital by EUR 3.440.000 by issuing 344.000 new common shares at a nominal value EUR 10 each and to amend article 5 of the Articles of Association of the Company.

After the explicit and unreserved statement of the other shareholder that it will not participate in the above mentioned share capital increase of "MEDIHELM S.A.", ELGEKA S.A. undertook to cover entirely this increase by payment in cash which will be realized in due time as it has been defined by article 11, par. 3 of L.2190/1920.

Consequently, the new share capital of "MEDIHELM S.A." will amount to a total EUR 6.748.000 divided into 674.800 nominal common shares with nominal value of EUR 10 each, while the participation percentage of ELGEKA S.A. in the above company increases from 98,92% to 99,47% approximately.

The above business development is in full conformity with the already announced strategic decision of ELGEKA Group for disengagement from the above activity and relates to the partial repayment of debt obligations of the subsidiary, which are secured with the parent company corporate guarantee.